Low- versus high-dose interferon alfa-2a in relapsed indolent non-Hodgkin's lymphoma.
VanderMolen LA, Steis RG, Duffey PL, Foon KA, Smith JW 2nd, Clark JW, Conlon K, Stevenson HC, Urba WJ, Hartmann LC, et al.
VanderMolen LA, et al. Among authors: stevenson hc.
J Natl Cancer Inst. 1990 Feb 7;82(3):235-8. doi: 10.1093/jnci/82.3.235.
J Natl Cancer Inst. 1990.
PMID: 2296053
Clinical Trial.
No abstract available.